logo-loader

Namaste Technologies subsidiary CannMart to sell CannTx's medical cannabis brand BOWER

Published: 13:50 26 Sep 2019 BST

Namaste Technologies Inc - Namaste Technologies Inc subsidiary CannMart will launch and sell CannTx Life Sciences Inc’s flagship medical cannabis brand BOWER
Toronto-based Namaste has been described as the 'Amazon of cannabis'

Namaste Technologies Inc (CVE:N) (OTCMKTS:NXTTF) announced Thursday that subsidiary CannMart will launch and sell CannTx Life Sciences Inc’s flagship medical cannabis brand BOWER.

As an additional value-added service, CannMart will process and package BOWER products through its Health Canada-licenced processing facility, according to a statement.

Namaste said this will allow CannMart to provide direct-to-consumer medical sales through CannMart.com and leverage its licence and approved facility to partner with licenced producers.

READ: Namaste Technologies introduces Cultivated Beauty’s hemp-based skincare products through CannMart

"CannMart is expanding its products and services to grow its online marketplace of quality products and demonstrate an additional value proposition to LPs," said Namaste CEO Meni Morim

"We're adding new services and sales channels for LPs who are licensed for cultivation only and those companies who have yet to receive regulatory approval for their sales and distribution licenses."

Mike Abbott, president and co-founder of privately owned CannTx, said CannMart offers a way to bring its products to market.  

"We've chosen CannMart to launch our online sales of quality cannabis products based on their unique value proposition," he said. "We have high-quality products and we believe this new channel for us will help alleviate some previous barriers to market."

CannTx products are available on CannMart's website effective immediately. 

Toronto-based Namaste, which has been described as the “Amazon of cannabis,” operates the largest global cannabis e-commerce platform with over 30 websites in more than 20 countries under a variety of brands.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Chesnara reports strong 2023 results with improved cash generation and...

Chesnara PLC (LSE:CSN) chief executive Steve Murray discusses the company's full-year results for 2023 with Proactive's Stephen Gunnion, describing them as strong and particularly highlighting £53 million in commercial cash generation and a dividend coverage of around 150%. The company has...

46 minutes ago